右美托咪定用于鞘内注射的研究进展

doi:10.3760/cma.j.issn.1007-1245.2024.03.003

摘要/Abstract

摘要：

为提高麻醉质量，减少鞘内局麻药的用量，进而降低不良反应发生率，鞘内局麻药与鞘内辅助药物的应用越来越受到关注。右美托咪定作为一种高选择性、特异性和强效性的α2-肾上腺素能受体激动剂一直是研究的热点药物，其镇痛效果已在各种手术中得到证实，但其鞘内应用的镇痛机制及安全性问题仍然是临床研究的难点。为更好提高麻醉质量，促进医疗事业的进步，本综述就右美托咪定用于鞘内注射的研究进展进行阐述。

关键词:

右美托咪定, 鞘内注射, 进展

Abstract:

In order to improve the quality of anesthesia, reduce the amount of intrathecal local anesthetics, and decrease the incidence of adverse reactions, the application of intrathecal local anesthetics and intrathecal adjuvant drugs has received more and more attention. Dexmedetomidine, as a kind of highly selective, specific, and potent α2-adrenergic agonist, has been a hotspot drug in research. Its analgesic effects have been proved in a variety of surgeries, but the analgesic mechanism of its intrathecal application and the issue of safety are still difficult problems in the clinical research. In order to better improve the quality of anesthesia and promote the advancement of the medical cause, the review on the progress of the research on the use of dexmedetomidine for intrathecal injection is described.

Key words:

Dexmedetomidine, Intrathecal injection, Progress

刘淑娇张全意.

右美托咪定用于鞘内注射的研究进展 [J]. 国际医药卫生导报, 2024, 30(3): 362-366.

Liu Shujiao, Zhang Quanyi.

Progress of dexmedetomidine for intrathecal injection [J]. International Medicine and Health Guidance News, 2024, 30(3): 362-366.

参考文献

[1] 郭曲练, 姚尚龙. 临床麻醉学[M].北京:4版·人民卫生出版,2016:108.
[2] 张冉,徐国亭. 右美托咪定在宫颈癌手术中的应用以及对VAS评分的影响[J]. 国际医药卫生导报,2022,28(23):3350-3355.DOI:10.3760/cma.j.issn.1007-1245. 2022.23.023.
[3] Bernards CM, Kopacz DJ. Effect of epinephrine on lidocaine clearance in vivo: a microdialysis study in humans[J].Anesthesiology,1999,91(4):962-968.DOI:10.1097/00000542-199910000-00015.
[4] Xiong C, Han C, Lv H, et al. Comparison of adjuvant pharmaceuticals for caudal block in pediatric lower abdominal and urological surgeries: a network meta-analysis[J].J Clin Anesth,2022,81:110907.DOI:10.1016/j.jclinane.2022.110907.
[5] Paramasivan A, Lopez-Olivo MA, Foong TW, et al. Intrathecal dexmedetomidine and postoperative pain: a systematic review and meta-analysis of randomized controlled trials[J].Eur J Pain,2020,24(7):1215-1227.DOI:10.1002/ejp.1575.
[6] Iirola T, Aantaa R, Laitio R, et al. Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients[J].Crit Care,2011,15(5):R257.DOI:10.1186/cc10518.
[7] Nazarian A, Christianson CA, Hua XY, et al. Dexmedetomidine and ST-91 analgesia in the formalin model is mediated by alpha2A-adrenoceptors: a mechanism of action distinct from morphine[J].Br J Pharmacol,2008,155(7):1117-1126.DOI:10.1038/bjp.2008.341.
[8] Kawasaki Y, Kumamoto E, Furue H, et al. Alpha 2 adrenoceptor-mediated presynaptic inhibition of primary afferent glutamatergic transmission in rat substantia gelatinosa neurons[J].Anesthesiology,2003,98(3):682-689.DOI:10.1097/00000542-200303000-00016.
[9] Sonohata M, Furue H, Katafuchi T, et al. Actions of noradrenaline on substantia gelatinosa neurones in the rat spinal cord revealed by in vivo patch recording[J].J Physiol,2004,555(Pt 2):515-26.DOI:10.1113/jphysiol.2003.054932.
[10] Yan X, Yadav R, Gao M, et al. Interleukin-1 beta enhances endocytosis of glial glutamate transporters in the spinal dorsal horn through activating protein kinase C[J].Glia,2014,62(7):1093-1109.DOI:10.1002/glia.22665.
[11] Schuster DJ, Kitto KF, Overland AC, et al. Protein kinase Cε is required for spinal analgesic synergy between delta opioid and alpha-2A adrenergic receptor agonist pairs[J].J Neurosci,2013,33(33):13538-13546.DOI:10.1523/JNEUROSCI.4013-12.2013.
[12] Overland AC, Kitto KF, Chabot-Doré AJ, et al. Protein kinase C mediates the synergistic interaction between agonists acting at alpha2-adrenergic and delta-opioid receptors in spinal cord[J].J Neurosci,2009,29(42):13264-13273.DOI:10.1523/JNEUROSCI.1907-09.2009.
[13] Li X, Zhang W. Influence of intrathecal injection with dexmedetomidine on the behavioral ability and analgesic effects on rats with neuropathic pain and expression of protein kinase C in the spinal dorsal horn[J].Exp Ther Med,2018,16(5):3835-3840.DOI:10.3892/etm.2018.6664.
[14] Gao YJ, Ji RR. c-Fos and pERK, which is a better marker for neuronal activation and central sensitization after noxious stimulation and tissue injury?[J].Open Pain J,2009,2:11-17.DOI:10.2174/1876386300902010011.
[15] Zhang H, Zhou F, Li C, et al. Molecular mechanisms underlying the analgesic property of intrathecal dexmedetomidine and its neurotoxicity evaluation: an in vivo and in vitro experimental study[J].PLoS One,2013,8(2):e55556.DOI:10.1371/journal.pone.0055556.
[16] Qian Y, Wang Q, Jiao J, et al. Intrathecal injection of dexmedetomidine ameliorates chronic neuropathic pain via the modulation of MPK3/ERK1/2 in a mouse model of chronic neuropathic pain[J].Neurol Res,2019,41(12):1059-1068.DOI:10.1080/01616412.2019.1672391.
[17] Shehabi Y, Howe BD, Bellomo R, et al. Early sedation with dexmedetomidine in critically Ill patients[J].N Engl J Med,2019,380(26):2506-2517.DOI:10.1056/NEJMoa1904710.
[18] Weerink MAS, Barends CRM, Muskiet ERR, et al. Pharmacodynamic interaction of remifentanil and dexmedetomidine on depth of sedation and tolerance of laryngoscopy[J].Anesthesiology,2019,131(5):1004-1017.DOI:10.1097/ALN.0000000000002882.
[19] Qi X, Chen D, Li G, et al. Comparison of intrathecal dexmedetomidine with morphine as adjuvants in cesarean sections[J].Biol Pharm Bull,2016,39(9):1455-1460.DOI:10.1248/bpb.b16-00145.
[20] Nasseri K, Ghadami N, Nouri B. Effects of intrathecal dexmedetomidine on shivering after spinal anesthesia for cesarean section: a double-blind randomized clinical trial[J].Drug Des Devel Ther,2017,11:1107-1113.DOI:10.2147/DDDT.S131866.
[21] Mostafa MF, Herdan R, Fathy GM, et al. Intrathecal dexmedetomidine versus magnesium sulphate for postoperative analgesia and stress response after caesarean delivery; randomized controlled double-blind study[J].Eur J Pain,2020,24(1):182-191.DOI:10.1002/ejp.1476.
[22] Pitman A, Suleman S, Hyde N, et al. Depression and anxiety in patients with cancer[J].BMJ,2018,361:k1415.DOI:10.1136/bmj.k1415.
[23] Liu HJ, Gao XZ, Liu XM, et al. Effect of intrathecal dexmedetomidine on spinal morphine analgesia in patients with refractory cancer pain[J].J Palliat Med,2014,17(7):837-840.DOI:10.1089/jpm.2013.0544.
[24] Huang G, Liu G, Zhou Z, et al. Successful treatment of refractory cancer pain and depression with continuous intrathecal administration of dexmedetomidine and morphine: a case report[J].J Pain Ther,2020,9(2):797-804.DOI:10.1007/s40122-020-00183-3.
[25] Fares KM, Mohamed SA, Abd El-Rahman AM, et al. Analgesic effect of intrathecal fentanyl vs dexmedetomidine as adjuvants to bupivacaine following abdominal surgery for cancer in children, a randomized trial[J].Pain Med,2020,21(11):2634-2641.DOI:10.1093/pm/pnaa259.
[26] Mohamed AA, Fares KM, Mohamed SA. Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery[J].Pain Physician,2012,15(4):339-348.
[27] Sharma I, Rana S, Choudhary B, et al. Comparative analgesic efficacy of intravenous vs intrathecal dexmedetomidine as an adjuvant to hyperbaric bupivacaine in subarachnoid block for below knee orthopaedic surgery[J].Indian J Anaesth,2020,64(6):463-469.DOI:10.4103/ija.IJA_219_20.
[28] Gautam B, Niroula S, Sharma M, et al. Effects of intrathecal dexmedetomidine as an adjuvant to hyperbaric bupivacaine for spinal anaesthesia in adults undergoing elective infra-umbilical surgery[J].JNMA J Nepal Med Assoc,2017,56(208):379-387.
[29] Qi X, Li Y, Rahe-Meyer N, et al. Intrathecal dexmedetomidine as adjuvant to ropivacaine in hysteroscopic surgery: a prospective, randomized control study[J].Int J Clin Pharmacol Ther,2016,54(3):185-192.DOI:10.5414/CP202427.
[30] Tug A, Hanci A, Turk HS, et al. Comparison of two different intranasal doses of dexmedetomidine in children for magnetic resonance imaging sedation[J].Paediatr Drugs,2015,17(6):479-485.DOI:10.1007/s40272-015-0145-1.
[31] Cimen ZS, Hanci A, Sivrikaya GU, et al. Comparison of buccal and nasal dexmedetomidine premedication for pediatric patients[J].Paediatr Anaesth,2013,23(2):134-138.DOI:10.1111/pan.12025.
[32] Abdallah FW, Brull R. Facilitatory effects of perineural dexmedetomidine on neuraxial and peripheral nerve block: a systematic review and meta-analysis[J].Br J Anaesth,2013,110(6):915-925.DOI:10.1093/bja/aet066.
[33] Kamal SM, Mohamed SA, Fares KM, et al. Immunosuppressive effect of intrathecal morphine, dexmedetomidine, or both in combination with bupivacaine on patients undergoing major abdominal cancer surgery[J].Pain Physician,2022,25(8):555-567.
[34] Konakci S, Adanir T, Yilmaz G, et al. The efficacy and neurotoxicity of dexmedetomidine administered via the epidural route[J].Eur J Anaesthesiol,2008,25(5):403-409.DOI:10.1017/S0265021507003079.
[35] Ozdamar D, Dayioglu H, Anik I, et al. Evaluation of the neurotoxicity of intrathecal dexmedetomidine on rat spinal cord (electromicroscopic observations)[J].Saudi J Anaesth,2018,12(1):10-15.DOI:10.4103/sja.SJA_143_17.
[36] Hou J, Xia Z, Xiao X, et al. Neurotoxicity of intrathecal injections of dexmedetomidine into the rat spinal dorsal horn[J].Neural Regen Res,2012,7(23):1765-1770.DOI:10.3969/j.issn.1673-5374.2012.23.001.
[37] Gupta M, Gupta P, Singh DK. Effect of 3 different doses of intrathecal dexmedetomidine (2.5µg, 5µg, and 10 µg) on subarachnoid block characteristics: a prospective randomized double blind dose-response Trial[J].Pain Physician,2016,19(3):E411-E420.
[38] Liu S, Zhao P, Cui Y, et al. Effect of 5-μg dose of dexmedetomidine in combination with intrathecal bupivacaine on spinal anesthesia: a systematic review and meta-analysis[J].Clin Ther,2020,42(4):676-690.e5.DOI:10.1016/j.clinthera.2020.02.009.
[39] Li XX, Li YM, Lv XL, et al. The efficacy and safety of intrathecal dexmedetomidine for parturients undergoing cesarean section: a double-blind randomized controlled trial[J].BMC Anesthesiol,2020,20(1):190.DOI:10.1186/s12871-020-01109-4.
[40] Rong H, Zhao Z, Feng J, et al. The effects of dexmedetomidine pretreatment on the pro- and anti-inflammation systems after spinal cord injury in rats[J].Brain Behav Immun,2017,64:195-207.DOI:10.1016/j.bbi.2017.03.006.